Table 5. Number of AEs at treatment with Tyloxapol vs. saline of the treated population (n = 21).

All AEs were mild in nature and self limited and possibly related to treatment except one patient* who discontinued the study due to intestinal bleeding.

		Tyloxapol	Saline
Shortness of breath		5	1
Coughing		5	2
Cold		3	0
Headache		2	0
Mucositis		0	2
Exacerbation		0	1
Other		5	1*
Total		20	7
	Patients with AEs	11	6
Relevant AEs	Including shortness of breath and Coughing	10	3
	Patients with relevant AEs	8	3